Stevanato Group (NYSE:STVN) Stock Price Down 7.8% – What’s Next?

Stevanato Group S.p.A. (NYSE:STVN) fell 7.8% on Tuesday . The company traded as low as €20.71 ($22.51) and last traded at €20.83 ($22.64). 76,087 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 345,984 shares. The stock had previously closed at €22.60 ($24.57).

Wall Street Analysts Forecast Growth

Several analysts have commented on STVN shares. Wolfe Research started coverage on Stevanato Group in a report on Friday, December 13th. They issued an “outperform” rating and a $28.00 price target for the company. Bank of America upped their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. William Blair reiterated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Morgan Stanley restated an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Finally, UBS Group decreased their target price on Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a report on Friday, March 7th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of €27.75 ($30.16).

Stevanato Group Stock Performance

The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The stock has a market capitalization of $6.00 billion, a PE ratio of 42.17, a P/E/G ratio of 7.18 and a beta of 0.60. The firm has a 50 day moving average of €21.30 and a 200-day moving average of €20.58.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, hitting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €352.68 million for the quarter, compared to the consensus estimate of €346.26 million. Research analysts forecast that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in STVN. Van Berkom & Associates Inc. acquired a new stake in Stevanato Group in the 4th quarter valued at approximately $39,000. Johnson Financial Group Inc. acquired a new position in Stevanato Group during the fourth quarter worth $41,000. Wells Fargo & Company MN lifted its holdings in Stevanato Group by 680.3% during the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock valued at $71,000 after purchasing an additional 2,830 shares during the last quarter. PNC Financial Services Group Inc. grew its position in Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock worth $123,000 after acquiring an additional 5,291 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its holdings in shares of Stevanato Group by 202.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock worth $162,000 after purchasing an additional 4,965 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.